Continue to Site

Medical Tubing and Extrusion

Medical tubing and extrusion technologies

Merit Medical spends $132.5M on acquisitions to expand its offerings

By

Merit Medical LogoAngioDynamics (Nasdaq:ANGO) announced that it completed the sale of its dialysis product portfolio to Merit Medical Systems.

It was part of a series of product acquisitions worth $132.5 million that Merit (Nasdaq: MMSI) has announced.

Latham, New York-based AngioDynamics sold its dialysis portfolio and the BioSentry product for $100 million in cash. The transaction includes the DuraFlow, DuraMax, Evenmore, Schon XL, Trio-CT and Vaxel Plus hemodialysis catheter brands. It also includes the BioSentry product, a tract sealant system biopsy brand.

AngioDynamics said in a news release that the combined product portfolio generated $32 million in sales in 2023.

Get the full story at our sister site, MassDevice.

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at swhooley@wtwhmedia.com.